IL6 and hepatocellular carcinoma: Since the host fails to overcome HCV infection, the persistent deregulation of immune factors such as IFN signaling, activation of NF-κB, TNF-α and IL-6-mediated signaling were found to be significantly associated with a poor prognosis for HCC development [62] and thus, presumably contribute to liver disease progression.